コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 rategy but with adjuvanted vaccine (expanded vaccination strategy).
2 ng immunomodulating molecules is a promising vaccination strategy.
3 ronment would further enhance this promising vaccination strategy.
4 Ab-deficient mice were not protected by this vaccination strategy.
5 in vaccination results and may guide future vaccination strategy.
6 ially affect the efficacy of the current HBV vaccination strategy.
7 uld be a value as a potential universal mass vaccination strategy.
8 immunity and is ideal for a prime-and-boost vaccination strategy.
9 g an Ebola virus disease outbreak via a ring vaccination strategy.
10 NYVAC (rNYVAC) vector and Env protein boost vaccination strategy.
11 novel vaccine platform for a prime-and-boost vaccination strategy.
12 velopment of improved influenza vaccines and vaccination strategies.
13 flexible context-specific dose regimens and vaccination strategies.
14 romising technological platform for improved vaccination strategies.
15 olecular adjuvants using DNA and DNA-protein vaccination strategies.
16 these antibodies are providing insights for vaccination strategies.
17 evaluate the protective potential of future vaccination strategies.
18 erlooked in the design and implementation of vaccination strategies.
19 interest in harnessing Tfh cells to improve vaccination strategies.
20 l responses, with important implications for vaccination strategies.
21 f adaptive immunity and an important goal of vaccination strategies.
22 d their potential role in improved influenza-vaccination strategies.
23 ection, and the development of novel mucosal vaccination strategies.
24 are generated will inform of ways to improve vaccination strategies.
25 e epidemiology and may inform genotyping and vaccination strategies.
26 rmining the feasibility and benefits of MenA vaccination strategies.
27 immune parameter for the evaluation of novel vaccination strategies.
28 this model to explore the impact of various vaccination strategies.
29 understanding of vaccine-induced immunity in vaccination strategies.
30 e valuable insights for future T(CD8+)-based vaccination strategies.
31 devise more effective adjunct treatment and vaccination strategies.
32 d may be employed for the design of improved vaccination strategies.
33 cell response may successfully guide subunit vaccination strategies.
34 eered CD8(+) T cells, as well as for peptide vaccination strategies.
35 disease and are important for peptide-based vaccination strategies.
36 olera transmission model to assess different vaccination strategies.
37 ortant implications for the design of future vaccination strategies.
38 ations for the development of more effective vaccination strategies.
39 ical observations, and have implications for vaccination strategies.
40 f T cell responses and a promising target in vaccination strategies.
41 potentially be modulated in support of novel vaccination strategies.
42 for the development of improved vaccines or vaccination strategies.
43 ct that could greatly affect the efficacy of vaccination strategies.
44 tribute to the formulation of more effective vaccination strategies.
45 DC lysis makes them attractive adjuvants for vaccination strategies.
46 y be considered as an important component in vaccination strategies.
47 es in direct testing of "proof of principal" vaccination strategies.
48 s uncertainty has important implications for vaccination strategies.
49 r transplantation biology, autoimmunity, and vaccination strategies.
50 (HIV) mandates the development of successful vaccination strategies.
51 improved diagnostic methods, and to seek new vaccination strategies.
52 ign of clinical trials of human vaccines and vaccination strategies.
53 sidered for the development of peptide-based vaccination strategies.
54 have important implications for prime-boost vaccination strategies.
55 d to define sites of vulnerability and guide vaccination strategies.
56 ited as adjuvants for future therapeutic and vaccination strategies.
57 alian host, in particular with regard to BCG vaccination strategies.
58 the development of different candidates and vaccination strategies.
59 us, it should be considered in future T cell-vaccination strategies.
60 should be considered for optimizing current vaccination strategies.
61 hat might benefit the rational design of new vaccination strategies.
62 children younger than 5 years of age in all vaccination strategies.
63 nfections that are highly evasive to current vaccination strategies.
64 s a priority for implementing evidence-based vaccination strategies.
65 and significantly contributes to prevention (vaccination) strategies.
66 y CTL is of increasing importance to develop vaccination strategies against a variety of established
70 nity.IMPORTANCE The development of effective vaccination strategies against dengue virus infection is
73 ofound implications for a transition to mass vaccination strategies against human influenza, and for
75 es are likely to play complementary roles in vaccination strategies against influenza: in this contex
78 t time the use of FcRs as a highly effective vaccination strategy against a highly virulent mucosal i
79 delivery of LJM11 by Listeria is a promising vaccination strategy against cutaneous leishmaniasis ind
84 n of M158 Moreover, our results suggest that vaccination strategies aimed at generating broad protect
85 utralizer provides the opportunity to design vaccination strategies aimed at generating similar bNAbs
86 itic cells (DDCs) is a rational approach for vaccination strategies aimed at improving humoral immune
87 +) DDCs is therefore a rational approach for vaccination strategies aimed at improving humoral respon
88 ortant implications for the design of future vaccination strategies aimed at increasing the number of
89 to other tumor antigens and are relevant for vaccination strategies aimed to induce long-term antibod
91 ave major implications for the design of new vaccination strategies and adoptive immunotherapies.
93 ideration of alternative maternally targeted vaccination strategies and can inform development of out
94 ults may have implications for the design of vaccination strategies and could lead to improvement of
96 d the impact of current and potential future vaccination strategies and explored the potential trade-
97 identified from these target Ags to optimize vaccination strategies and facilitate monitoring of tumo
98 icting the spread of epidemics and designing vaccination strategies and from finding friends to uncov
99 ector cell activation, with implications for vaccination strategies and immunotherapeutic approaches.
100 mory T cells arise is important for rational vaccination strategies and improved therapeutic interven
102 es nontoxic PSMalpha3 derivatives for active vaccination strategies and lays the foundation for futur
103 ve the potential to have an impact on future vaccination strategies and our understanding of the role
104 se invasive disease is of concern for future vaccination strategies and should promote rigorous surve
106 mall-world networks, to random networks, and vaccination strategy and effort interact to influence th
107 placement (cohort) and lifetime (continuous) vaccination strategies, and applied it to a Salmonella C
108 ctiveness of alternative maternally targeted vaccination strategies (antenatal delivery vs. postnatal
109 milar to the estimated costs of the reactive vaccination strategy (approximately 10 million US dollar
113 d full-length HAs, confirming that cHA-based vaccination strategies are superior at generating stalk-
116 re, the potential of phosphorylcholine-based vaccination strategies as a novel tool for the preventio
117 ing peptide that may be harnessed as a novel vaccination strategy as well as a therapeutics delivery
119 ratory models of tuberculosis has shown that vaccination strategies based on heterologous prime-boost
120 portant considerations in the development of vaccination strategies based on live-attenuated viruses.
124 ave important implications for the design of vaccination strategies because it may be necessary to es
125 rance of infection can be achieved through a vaccination strategy, but to date, the results have been
128 t combining engineered T cells with specific vaccination strategies can improve the active tumor ther
130 INTERPRETATION: The results show that a ring vaccination strategy can be rapidly and safely implement
131 tudy, we employed a heterologous prime-boost vaccination strategy comprising intradermally administer
134 issue of Immunity, Chen et al. propose a new vaccination strategy, demonstrating that Th17 memory cel
135 There were many developments to improve vaccination strategies, demonstration of new molecules i
137 for the FVB/N mouse, but we propose that the vaccination strategy determines the dominance of epitope
138 a and its vaccine to compare Nash equilibria vaccination strategies driven by self-interest with util
141 s lives before it was eradicated by a simple vaccination strategy: epicutaneous application of the re
142 opose that a reason that current therapeutic vaccination strategies fail to resurrect/sustain T cell
145 owever, numerous clinical trials are testing vaccination strategies for AD, suggesting that T and B c
146 ccinate against diseases affecting all ages, vaccination strategies for adolescents need to be review
149 The development of autoantigen-specific vaccination strategies for Foxp3(+)Treg-induction and pr
150 rk has significant implications for improved vaccination strategies for future influenza pandemics.
152 viously used in the United Kingdom to inform vaccination strategies for influenza, with extensions to
154 ns of augmenting the immune response both in vaccination strategies for microbial infections and in t
156 these studies suggest previously unexplored vaccination strategies for pathogen-associated antigens
157 ese findings introduce previously unexplored vaccination strategies for pathogens that target the B-1
158 We also summarize infection control and vaccination strategies for patients, family members, and
159 ould prove valuable in designing therapeutic vaccination strategies for persistent viral infections.
162 and may support the development of novel DC vaccination strategies for transplantations, as well as
165 NA approach appears to represent a promising vaccination strategy for CHIK and other alphaviral disea
166 se results suggest the potential use of this vaccination strategy for future clinical applications.
169 ped and previously reported on a therapeutic vaccination strategy for indolent B-cell lymphoma that c
171 of population-level immunity and the optimal vaccination strategy for long-term control of MenA menin
172 ecision makers on maternal immunization as a vaccination strategy for protection of young infants aga
173 restoration of Ag-specific tolerance through vaccination strategies, for example in type 1 diabetes p
174 cquired immunity could benefit the design of vaccination strategies, for example those aimed at elici
177 istory of Ag experience and that prime-boost vaccination strategies have important consequences on me
180 Thus, the LVS DeltacapB-rLm/iglC prime-boost vaccination strategy holds substantial promise for a vac
181 enhance antiviral immunity and promote safer vaccination strategies; however, understanding the balan
182 nclusion of multiple variants in prime-boost vaccination strategies improves recognition of variant v
183 the potential effectiveness of age-specific vaccination strategies in averting RSV incidence, we dev
185 er and warrants consideration of therapeutic vaccination strategies in combination with PD-1 blockade
187 nd suggest a broad counterintuitive role for vaccination strategies in mitigating undesirable immune
188 ave important implications for the design of vaccination strategies in neoplastic or chronic infectio
192 ation model to evaluate the effectiveness of vaccination strategies in the United States for fall 200
193 luated a multivalent live-attenuated mucosal vaccination strategy in a murine model of acute P. aerug
195 d vaccines are yet available, but in a trial vaccination strategy in West Africa, recombinant, infect
196 the findings were instrumental in optimizing vaccination strategy in western Uttar Pradesh with respe
198 then compared the impact of a mine-targeted vaccination strategy, in which miners were vaccinated wh
199 udies are needed to determine whether a ring vaccination strategy, in which vaccine is given quickly
200 erize the impact and trade-offs of potential vaccination strategies, including the introduction of in
203 ) would be improved when incorporating these vaccination strategies into the DNA priming phase, as de
206 ariants for a given immunogen in prime-boost vaccination strategies is one approach that aims to impr
210 -29 years of age, the most effective modeled vaccination strategy is to conduct mass vaccination camp
212 These data suggest that mucosal pneumococcal vaccination strategies may be important for vulnerable p
213 V-A16 and EV-A71 and we explore what spatial vaccination strategies may best reduce the burden of HFM
214 et of epidemic, during which the outcomes of vaccination strategies may differ significantly and are
217 erd effects might render a year-round infant vaccination strategy more appealing, although it is curr
218 otal number of memory cells, indicating that vaccination strategies need to consider this issue.
220 Our findings shift the focus of pandemic vaccination strategies onto younger populations and illu
221 PLs could improve the therapeutic outcome of vaccination strategies or can be used for ex vivo enrich
222 ense burden of tuberculosis, new vaccines or vaccination strategies, or both, are urgently needed.
224 demonstrate for the first time that an oral vaccination strategy prevents Pneumocystis infection.
231 will allow for an exploration of alternative vaccination strategies such as different age-spacings, f
233 not as efficient as many other potential HPV vaccination strategies, such as increasing primary 9vHPV
234 the development of antimicrobial therapies, vaccination strategies, targeted public health measures,
235 o, and imply that more effective therapeutic vaccination strategies targeting CD8+ Tcm in patients on
236 rstanding initiation of immune responses and vaccination strategies targeting DCs and activated monoc
240 enicity of rSeV-based vaccines, but all four vaccination strategies tested resulted in complete prote
242 they recognize the virus, and we discuss new vaccination strategies that aim to mimic natural evoluti
243 rates and evaluate the outcomes of different vaccination strategies that are influenced by the level
244 oal of AIDS vaccine development is to design vaccination strategies that can elicit broad and potent
245 e way for the development of next-generation vaccination strategies that completely prevent malaria.
246 tant implications for the design of maternal vaccination strategies that could synergize with ART dur
247 elopment of recombinant and vectored subunit vaccination strategies that have, however, not yet match
249 exploration of the MV1-F4 vector modality in vaccination strategies that may limit HIV-1 infectivity.
250 y of ADCC as a viable approach for targeting vaccination strategies that promote FcgammaRI/III scaven
251 T-2 adapters, our results suggest that human vaccination strategies that specifically facilitate SLAM
252 ugh the peripheral tissues and highlight new vaccination strategies that take advantage of this newly
253 ysis of a PCV trial can assist in developing vaccination strategies that target specific geographic s
254 on of YF-17D, and highlight the potential of vaccination strategies that use combinations of differen
255 up the possibility for microneedle-based HIV vaccination strategies that, once fully developed, will
257 ay allow the development of an efficient HIV vaccination strategy that is capable of inducing both ro
258 cles, or dense bodies, may constitute a safe vaccination strategy that mimics natural infection.
259 tive, wildlife epidemiologists could adopt a vaccination strategy that protects a population from the
260 th an urgent need for new and more efficient vaccination strategies, the integration of these data wi
261 me are critical to allow the optimization of vaccination strategies to effectively stimulate immune r
263 ble public health interest in developing new vaccination strategies to improve control of pertussis.
265 f countries to implement maternally targeted vaccination strategies to protect vulnerable infants, bu
267 ces and will help policy makers to formulate vaccination strategies to reduce the burden of severely
268 DCs present a promising cellular target for vaccination strategies to resolve chronic liver infectio
270 ous prime-boost may provide a more effective vaccination strategy to broaden the antibody responses t
271 of NY-ESO-1 to APC appears to be a promising vaccination strategy to efficiently generate integrated
272 ion peptide, it may be possible to develop a vaccination strategy to induce these CD4(+) T cells, whi
274 xtremely useful for modeling the efficacy of vaccination strategies under the real-world conditions o
278 ims to compare the impact of alternative HPV vaccination strategies, using data from Sweden, a high-i
282 d Gram-positive bacteria-dendritic cell (DC) vaccination strategy, we determined that in vivo depleti
287 ated with live P. murina using a prime-boost vaccination strategy were protected from a subsequent lu
288 n together, our findings provide a potential vaccination strategy where heterologous influenza immuni
289 g the first 10 years after the start of each vaccination strategy, whereas the existing program yield
292 e modified vaccinia virus Ankara (MVA)-boost vaccination strategy, which uses mismatched Gag immunoge
298 parameters into uncertainty in which of two vaccination strategies would provide a better response t
300 e vaccine supply, this alternative influenza vaccination strategy would help control interpandemic in
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。